211 related articles for article (PubMed ID: 19158499)
1. Cdk5 acts as a mediator of neuronal cell cycle re-entry triggered by amyloid-beta and prion peptides.
Lopes JP; Oliveira CR; Agostinho P
Cell Cycle; 2009 Jan; 8(1):97-104. PubMed ID: 19158499
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclin-dependent kinase 5 in the neurodegenerative process triggered by amyloid-Beta and prion peptides: implications for Alzheimer's disease and prion-related encephalopathies.
Lopes JP; Oliveira CR; Agostinho P
Cell Mol Neurobiol; 2007 Nov; 27(7):943-57. PubMed ID: 17965932
[TBL] [Abstract][Full Text] [Related]
3. Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron.
Chao AC; Chen CH; Wu MH; Hou BY; Yang DI
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118628. PubMed ID: 31884068
[TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
Lopes JP; Oliveira CR; Agostinho P
Aging Cell; 2010 Feb; 9(1):64-77. PubMed ID: 19895631
[TBL] [Abstract][Full Text] [Related]
5. Id1 and Sonic Hedgehog Mediate Cell Cycle Reentry and Apoptosis Induced by Amyloid Beta-Peptide in Post-mitotic Cortical Neurons.
Chao AC; Chen CH; Chang SH; Huang CT; Hwang WC; Yang DI
Mol Neurobiol; 2019 Jan; 56(1):465-489. PubMed ID: 29721855
[TBL] [Abstract][Full Text] [Related]
6. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
[TBL] [Abstract][Full Text] [Related]
7. Tau phosphorylation by cdk5 and Fyn in response to amyloid peptide Abeta (25-35): involvement of lipid rafts.
Hernandez P; Lee G; Sjoberg M; Maccioni RB
J Alzheimers Dis; 2009; 16(1):149-56. PubMed ID: 19158430
[TBL] [Abstract][Full Text] [Related]
8. Cdk5-mediated inhibition of APC/C-Cdh1 switches on the cyclin D1-Cdk4-pRb pathway causing aberrant S-phase entry of postmitotic neurons.
Veas-Pérez de Tudela M; Maestre C; Delgado-Esteban M; Bolaños JP; Almeida A
Sci Rep; 2015 Dec; 5():18180. PubMed ID: 26658992
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of the cyclin-dependent kinase 5 activator, p35, by paclitaxel decreases beta-amyloid toxicity in cortical neurons.
Li G; Faibushevich A; Turunen BJ; Yoon SO; Georg G; Michaelis ML; Dobrowsky RT
J Neurochem; 2003 Jan; 84(2):347-62. PubMed ID: 12558997
[TBL] [Abstract][Full Text] [Related]
10. Cdk5: multitasking between physiological and pathological conditions.
Lopes JP; Agostinho P
Prog Neurobiol; 2011 Jun; 94(1):49-63. PubMed ID: 21473899
[TBL] [Abstract][Full Text] [Related]
11. Activation of cell cycle proteins in transgenic mice in response to neuronal loss but not amyloid-beta and tau pathology.
Lopes JP; Blurton-Jones M; Yamasaki TR; Agostinho P; LaFerla FM
J Alzheimers Dis; 2009; 16(3):541-9. PubMed ID: 19276549
[TBL] [Abstract][Full Text] [Related]
12. p35/Cyclin-dependent kinase 5 is required for protection against beta-amyloid-induced cell death but not tau phosphorylation by ceramide.
Seyb KI; Ansar S; Li G; Bean J; Michaelis ML; Dobrowsky RT
J Mol Neurosci; 2007; 31(1):23-35. PubMed ID: 17416967
[TBL] [Abstract][Full Text] [Related]
13. Interplay between MEK-ERK signaling, cyclin D1, and cyclin-dependent kinase 5 regulates cell cycle reentry and apoptosis of neurons.
Modi PK; Komaravelli N; Singh N; Sharma P
Mol Biol Cell; 2012 Sep; 23(18):3722-30. PubMed ID: 22833568
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
[TBL] [Abstract][Full Text] [Related]
15. Sulforaphene, a CDK5 Inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer's disease via reducing Aβ Deposition, tau hyperphosphorylation and synaptic dysfunction.
Yang W; Xu QQ; Yuan Q; Xian YF; Lin ZX
Int Immunopharmacol; 2023 Jan; 114():109504. PubMed ID: 36508924
[TBL] [Abstract][Full Text] [Related]
16. Deregulated Cdk5 triggers aberrant activation of cell cycle kinases and phosphatases inducing neuronal death.
Chang KH; Vincent F; Shah K
J Cell Sci; 2012 Nov; 125(Pt 21):5124-37. PubMed ID: 22899714
[TBL] [Abstract][Full Text] [Related]
17. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
18. Fuzhisan, a Chinese herbal medicine, inhibits beta-amyloid-induced neurotoxicity and tau phosphorylation through calpain/Cdk5 pathway in cultured cortical neurons.
Zhang Z; Zhao R; Tang Y; Wen S; Wang D; Qi J
Neurochem Res; 2011 May; 36(5):801-11. PubMed ID: 21243427
[TBL] [Abstract][Full Text] [Related]
19. CDK5 Participates in Amyloid-β Production by Regulating PPARγ Phosphorylation in Primary Rat Hippocampal Neurons.
Quan Q; Qian Y; Li X; Li M
J Alzheimers Dis; 2019; 71(2):443-460. PubMed ID: 31403945
[TBL] [Abstract][Full Text] [Related]
20. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
